Literature DB >> 29492354

Spectral Analysis Methods Based on Background Subtraction and Curvature Calculation Used in the Detection or Quantification of Hemolysis and Icterus in Blood-derived Clinical Samples.

Toan Huynh1, Michael J Lai1, Yang L Liu1, Linda Ly1, Xinwei Gong2, Kathryn R Rommel1, Daniel L Young2.   

Abstract

Objective We aimed to find new methods to detect and quantify hemolysis and icterus which may cause assay biases. These methods need to determine each of these interferents in the presence of various other interferents. They also need to have less stringent requirements in development and implementation than those conventional analyzers currently must satisfy. Design and methods We developed two spectral analysis methods that obtain absorption signals of interest by background subtraction or by calculating the spectral curvatures near the peaks of interest. We optimized and tested the performance of these methods using a plasma sample set with permutations of the levels of hemolysis, icterus, and lipemia (using 510 samples in total). Results The processed signals correlated well with concentrations of hemoglobin and bilirubin, indicators of hemolysis and icterus, respectively. Through iterations of randomly splitting the samples for calibration and testing, the two new methods performed as well as those used on conventional analyzers. We demonstrated that the two methods can lessen the application requirements of 1) prior knowledge of the absorption spectra of individual interferents, 2) calibration over a wide concentration range for each interferent, and 3) the need for full-range spectrophotometers spanning most of the ultraviolet/visible spectrum. We also proposed a hardware setup to detect and quantify hemolysis or icterus with a camera and two optical filters. Conclusions This work indicates that new methods of spectral analysis can reduce practical constraints in the development of interference screening systems. These methods could also benefit other assays that rely on reading spectral signals.

Entities:  

Keywords:  chemistry; interfering substances; point-of-care; sample integrity; spectroscopy

Year:  2017        PMID: 29492354      PMCID: PMC5820094          DOI: 10.7759/cureus.1965

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  18 in total

1.  Icterus index determined with the spectrophotometer, corrected for turbidity and hemoglobin.

Authors:  J FOG
Journal:  Scand J Clin Lab Invest       Date:  1958       Impact factor: 1.713

2.  Methods for measuring plasma hemoglobin in micromolar concentration compared.

Authors:  V F Fairbanks; S C Ziesmer; P C O'Brien
Journal:  Clin Chem       Date:  1992-01       Impact factor: 8.327

3.  A mobile phone-based approach to detection of hemolysis.

Authors:  Edikan Archibong; Karthik Raj Konnaiyan; Howard Kaplan; Anna Pyayt
Journal:  Biosens Bioelectron       Date:  2016-08-16       Impact factor: 10.618

4.  Plasma hemoglobin determination by recording derivative spectrophotometry.

Authors:  F G Soloni; M T Cunningham; K Amazon
Journal:  Am J Clin Pathol       Date:  1986-03       Impact factor: 2.493

5.  Quantitative measurement of plasma hemoglobin by second derivative spectrophotometry.

Authors:  G J Sanderink; H J van Rijn
Journal:  Clin Chim Acta       Date:  1985-02-28       Impact factor: 3.786

6.  Evaluation of absorption and first- and second-derivative spectra for simultaneous quantification of bilirubin and hemoglobin.

Authors:  M F Merrick; H L Pardue
Journal:  Clin Chem       Date:  1986-04       Impact factor: 8.327

7.  Direct spectrophotometry of serum hemoglobin: an Allen correction compared with a three-wavelength polychromatic analysis.

Authors:  D A Noe; V Weedn; W R Bell
Journal:  Clin Chem       Date:  1984-05       Impact factor: 8.327

8.  An evaluation of a spectrophotometric scanning technique for measurement of plasma hemoglobin.

Authors:  S E Kahn; B F Watkins; E W Bermes
Journal:  Ann Clin Lab Sci       Date:  1981 Mar-Apr       Impact factor: 1.256

9.  Influence of hemolysis on routine clinical chemistry testing.

Authors:  Giuseppe Lippi; Gian Luca Salvagno; Martina Montagnana; Giorgio Brocco; Gian Cesare Guidi
Journal:  Clin Chem Lab Med       Date:  2006       Impact factor: 3.694

10.  A lipemia-independent NanoDrop(®)-based score to identify hemolysis in plasma and serum samples.

Authors:  Valentina Appierto; Maurizio Callari; Elena Cavadini; Daniele Morelli; Maria Grazia Daidone; Paola Tiberio
Journal:  Bioanalysis       Date:  2014-05       Impact factor: 2.681

View more
  2 in total

1.  Visual Assessment of Blood Plasma versus Optical Transmittance and Refractive Index Measurements for Quantifying Lipemia.

Authors:  Roberto Márquez-Islas; Argelia Pérez-Pacheco; Rosa Quispe-Siccha; Laura Beatriz Salazar-Nieva; Augusto García-Valenzuela
Journal:  Diagnostics (Basel)       Date:  2022-02-16

2.  Engineering of a miniaturized, robotic clinical laboratory.

Authors:  Marilyn B Nourse; Kate Engel; Samartha G Anekal; Jocelyn A Bailey; Pradeep Bhatta; Devayani P Bhave; Shekar Chandrasekaran; Yutao Chen; Steven Chow; Ushati Das; Erez Galil; Xinwei Gong; Steven F Gessert; Kevin D Ha; Ran Hu; Laura Hyland; Arvind Jammalamadaka; Karthik Jayasurya; Timothy M Kemp; Andrew N Kim; Lucie S Lee; Yang Lily Liu; Alphonso Nguyen; Jared O'Leary; Chinmay H Pangarkar; Paul J Patel; Ken Quon; Pradeep L Ramachandran; Amy R Rappaport; Joy Roy; Jerald F Sapida; Nikolay V Sergeev; Chandan Shee; Renuka Shenoy; Sharada Sivaraman; Bernardo Sosa-Padilla; Lorraine Tran; Amanda Trent; Thomas C Waggoner; Dariusz Wodziak; Amy Yuan; Peter Zhao; Daniel L Young; Channing R Robertson; Elizabeth A Holmes
Journal:  Bioeng Transl Med       Date:  2018-01-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.